Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

http://www.wikidata.org/entity/Q24651026

about

Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88 Functional consequences of the subdomain organization of the sulfs Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances An update of biochemical markers of hepatocellular carcinoma Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair A targeted glycan-related gene screen reveals heparan sulfate proteoglycan sulfation regulates WNT and BMP trans-synaptic signaling Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers High Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice: Insight into the Connection between Activation of Oncotargets and Oncogene Addiction Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development Heparan sulfate signaling in cancer Common variation in GPC5 is associated with acquired nephrotic syndrome Exploring the molecular causes of hepatitis B virus vaccination response: an approach with epigenomic and transcriptomic data.Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate.Regulation of intracellular signaling by extracellular glycan remodeling.Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development.Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma.Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines.Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions.Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival.Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study.Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells.Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.

P2860

Q24328759-D7BFBC29-B45B-41D2-B79A-1A6EFB0C0632 Q24337783-E9CA19DA-A24C-49B2-8CDF-47E6F31C2851 Q26740617-7721B165-7E33-4690-9C02-D25DB406D80A Q26745338-E42E56D5-68C4-4ED3-B74F-25920E276A91 Q26752700-C80D556E-27AB-466E-B64F-64FD069AFE5E Q27015134-0953FC9D-F7C3-485D-A1FE-2D05210826C4 Q27310845-E91D9C99-1D51-4DBF-9BF8-CE01877178A9 Q27330302-E1530F1A-91B5-43D4-B87B-F0BCA104F7A0 Q28304465-F35F66FB-5721-4B80-95FF-3A7BEC24C882 Q28389551-3479E2A5-332C-405D-BB8B-086477240C50 Q28394701-39D7CECA-AB40-4D67-AACA-63AC16B8D7C8 Q28512564-10BCF3C7-B371-4E20-9CE5-05A723167A01 Q28534127-0E547204-D130-4E69-A9CB-B02B11EC4C26 Q28587262-BAE0AF35-849B-4AC8-A6FF-FF94E49E2C45 Q28657828-2BA4AE15-AF9C-414E-B6B8-17DAFB33D423 Q28943292-259F5F0E-EEC5-479A-B619-F80E829B0CEB Q30773873-E4C8E86B-9A6D-4F7F-A3EE-064F3213CB74 Q33401779-6774A36A-7E88-4256-89E4-C4A8672A6F30 Q33675552-5ECC4233-D34A-464F-9A47-42A45708CC62 Q33803148-4E0C6C5F-E81C-4938-8855-B590B393E0BB Q33828849-012D39FB-0AD2-4C10-B710-A528A91C9FCD Q33898309-F6212F7C-7376-475D-B0BA-668355434A31 Q34044419-4535F0B5-A605-43AE-B1A9-770A89AE8D44 Q34050837-9A14AE67-3C59-4202-9F2E-2F777D228AFF Q34348377-46BB0899-C84F-4E96-A506-65C72321CBF2 Q35224629-7152FD9D-214A-4249-900A-CC0C0027BF37 Q35341540-C452EAEC-ED21-4B61-B2D0-19370EC509F3 Q35623603-2F6253DB-18AF-4F9E-B8B5-0664EE105943 Q35659513-FDF44AED-D957-4E75-952E-9EDFB8284DED Q35780214-F9E8AEDD-F244-4C3B-8B8C-A1AE8F299182 Q35840419-8CCD67B1-DB18-42C3-9A49-36186BDBCC22 Q35903837-30CD7BF3-2E78-48C1-83CA-B2B16EE96C97 Q35925048-F9523D0A-2447-42FF-82CC-132AC841A538 Q36128222-746E7A4B-197A-4A8C-97DC-893AFEB16125 Q36496211-76F97869-C11F-4BB1-BAE3-016CBF386315 Q36565975-4B383678-2BFF-40DC-946A-6227082370D1 Q36572132-B3EED29D-96D7-4989-ABC6-8F26F16A3936 Q36747200-C16E5965-4FC1-4B48-8760-8A84AC26B32C Q36953585-9A908F0C-DA58-4F41-A620-787F7E15BF21 Q37042791-52B05176-E281-4E24-BC48-1E3A252EF5F1

P2860

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

http://www.wikidata.org/entity/Q24651026

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@ast

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@en

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@nl

type

label

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@ast

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@en

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@nl

prefLabel

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@ast

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@en

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@nl

P1433

Q24651026-B09D27D8-A81B-4A4C-B77A-6B45F4221691

P1476

Q24651026-0C82F6B6-6211-489C-B2BC-4CCF27484D33

P2093

Q24651026-137E6B11-CDEA-4D5C-98C4-4A1A9F538BD3

Q24651026-17042074-4C89-475D-96C9-E785C67171AF

Q24651026-59D6F636-DFBF-455C-8C20-A981ECB5264B

Q24651026-6D82A221-FE98-4B67-BCDB-D7481BBB4385

Q24651026-6D83BAA2-D100-4F3C-B42B-3B03D6D71CD4

Q24651026-82D734E2-F6CB-4426-8A32-191A22FF2D7C

Q24651026-87E85478-7B6D-429B-8F5F-6F6CDCEB79F9

Q24651026-972C89F3-14FD-4ED1-94F8-B94DD46EFE8E

Q24651026-AA50587E-B874-42E4-A371-A61D78AB9661

Q24651026-ABEA931F-FC15-4E29-9C6C-52EAD07BC7EF

P2860

Q24651026-04D273C9-C7BD-42D1-BE04-571066648A6C

Q24651026-106EF8D4-6D15-4B87-9C76-A65AF93E9BCF

Q24651026-10BEE88C-25EB-4F18-8FF7-C7C3AD0E1F28

Q24651026-197A5E8C-5227-46FB-8E1A-A0ED5E583579

Q24651026-1AA3585E-D5C7-4E69-813B-9C218D1F25F5

Q24651026-1DC7ACB9-C7BC-4FD1-9C6D-5FE2AFA320FC

Q24651026-2577B956-26FD-48FB-B949-C1497EDA109E

Q24651026-27B1469C-4443-4643-A2D1-B777EA36700B

Q24651026-30E953A0-1B21-48AD-A83B-6411DDB5E1D1

Q24651026-38F1233B-DEAD-44DB-93E0-C3366F0F5F77

P304

Q24651026-C3568CC8-631D-4FD5-BDF7-9BC8603BC010

P31

Q24651026-A00DD165-915B-4469-9F54-1C67FB759D44

P3181

Q24651026-E692ED5C-C3D2-4E39-82E6-C6BCB9C739FF

P356

Q24651026-89860103-5E8B-49F1-B833-930420D9D82A

P407

Q24651026-51079E86-E367-4016-9D86-A89398F260F6

P433

Q24651026-F173F272-66B4-4F3E-AFEC-2AC9F35E201E

P478

Q24651026-ABBDEDE2-9F24-4057-8F23-65EE867E29C8

P577

Q24651026-1D80B535-D746-4856-8ABE-682FF4ACEEF4

P5875

Q24651026-70A24CF9-5D4F-4530-8C78-C65BB0AE1853

P698

Q24651026-473368A2-D012-46D2-B6AC-07BD99A9C52E

P932

Q24651026-86EEF078-34A2-4E8E-A784-C7FFB5C54556

P3181

P356

P1433

P1476

Sulfatase 2 up-regulates glypi ...... al in hepatocellular carcinoma

@en

P2093

Abdirashid M Shire

http://www.w3.org/2001/XMLSchema#string

Alex A Adjei

http://www.w3.org/2001/XMLSchema#string

Catherine D Moser

http://www.w3.org/2001/XMLSchema#string

Chunrong Yu

http://www.w3.org/2001/XMLSchema#string

Dalbir S Sandhu

http://www.w3.org/2001/XMLSchema#string

David M Nagorney

http://www.w3.org/2001/XMLSchema#string

Hajime Isomoto

http://www.w3.org/2001/XMLSchema#string

Hongzhi Zou

http://www.w3.org/2001/XMLSchema#string

Ileana Aderca

http://www.w3.org/2001/XMLSchema#string

Jin-Ping Lai

http://www.w3.org/2001/XMLSchema#string

P2860

HSulf-1 inhibits angiogenesis and tumorigenesis in vivo

Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.

HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.

Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer

Hsulf-1 regulates growth and invasion of pancreatic cancer cells

Global cancer statistics, 2002

The consensus coding sequences of human breast and colorectal cancers

Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

P304

1211-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

406532

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.22202

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5534687

http://www.w3.org/2001/XMLSchema#string

P698

18318435

http://www.w3.org/2001/XMLSchema#string

P932

2536494

http://www.w3.org/2001/XMLSchema#string